Trial Profile
COmbination Strategy on renal function of the benidipine or diuretics treatMent with RAS inhibitOrs in CKD hypertensive population.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Benidipine (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms COSMO-CKD
- 14 Jun 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 Jul 2009 New trial record